These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

749 related items for PubMed ID: 7601011

  • 1. Pharmacological management of gastro-oesophageal reflux disease.
    Klinkenberg-Knol EC, Festen HP, Meuwissen SG.
    Drugs; 1995 May; 49(5):695-710. PubMed ID: 7601011
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
    Hatlebakk JG, Berstad A.
    Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
    [Abstract] [Full Text] [Related]

  • 3. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
    van Pinxteren B, Sigterman KE, Bonis P, Lau J, Numans ME.
    Cochrane Database Syst Rev; 2010 Nov 10; (11):CD002095. PubMed ID: 21069670
    [Abstract] [Full Text] [Related]

  • 4. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
    van Pinxteren B, Numans ME, Bonis PA, Lau J.
    Cochrane Database Syst Rev; 2006 Jul 19; (3):CD002095. PubMed ID: 16855986
    [Abstract] [Full Text] [Related]

  • 5. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
    Sigterman KE, van Pinxteren B, Bonis PA, Lau J, Numans ME.
    Cochrane Database Syst Rev; 2013 May 31; 2013(5):CD002095. PubMed ID: 23728637
    [Abstract] [Full Text] [Related]

  • 6.
    Swedish Council on Health Technology Assessment.
    ; 2007 10 31. PubMed ID: 28876800
    [Abstract] [Full Text] [Related]

  • 7. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
    van Pinxteren B, Numans ME, Bonis PA, Lau J.
    Cochrane Database Syst Rev; 2000 10 31; (2):CD002095. PubMed ID: 10796857
    [Abstract] [Full Text] [Related]

  • 8. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
    van Pinxteren B, Numans ME, Bonis PA, Lau J.
    Cochrane Database Syst Rev; 2001 10 31; (4):CD002095. PubMed ID: 11687139
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
    van Pinxteren B, Numans ME, Bonis PA, Lau J.
    Cochrane Database Syst Rev; 2004 Oct 18; (4):CD002095. PubMed ID: 15495027
    [Abstract] [Full Text] [Related]

  • 11. Pharmacological treatment of children with gastro-oesophageal reflux.
    Tighe M, Afzal NA, Bevan A, Hayen A, Munro A, Beattie RM.
    Cochrane Database Syst Rev; 2014 Nov 24; 2014(11):CD008550. PubMed ID: 25419906
    [Abstract] [Full Text] [Related]

  • 12. Omeprazole. A review of its use in Helicobacter pylori infection, gastro-oesophageal reflux disease and peptic ulcers induced by nonsteroidal anti-inflammatory drugs.
    Langtry HD, Wilde MI.
    Drugs; 1998 Sep 24; 56(3):447-86. PubMed ID: 9777317
    [Abstract] [Full Text] [Related]

  • 13. Pharmacotherapy for chronic gastro-oesophageal reflux disease and Barrett's oesophagus.
    Wurm P, de Caestecker J.
    Expert Opin Pharmacother; 2003 Jul 24; 4(7):1049-61. PubMed ID: 12831333
    [Abstract] [Full Text] [Related]

  • 14. Pathophysiology and treatment of gastro-oesophageal reflux disease.
    Vantrappen G, Janssens J.
    Scand J Gastroenterol Suppl; 1989 Jul 24; 165():7-12; discussion 27-8. PubMed ID: 2574907
    [Abstract] [Full Text] [Related]

  • 15. Results of short-and long-term medical treatment of gastroesophageal reflux disease (GERD).
    Pohle T, Domschke W.
    Langenbecks Arch Surg; 2000 Aug 24; 385(5):317-23. PubMed ID: 11026702
    [Abstract] [Full Text] [Related]

  • 16. Medical management of nocturnal symptoms of gastro-oesophageal reflux disease in the elderly.
    Gawrieh S, Shaker R.
    Drugs Aging; 2003 Aug 24; 20(7):509-16. PubMed ID: 12749748
    [Abstract] [Full Text] [Related]

  • 17. The effect of cisapride in maintaining symptomatic remission in patients with gastro-oesophageal reflux disease.
    Hatlebakk JG, Johnsson F, Vilien M, Carling L, Wetterhus S, Thøgersen T.
    Scand J Gastroenterol; 1997 Nov 24; 32(11):1100-6. PubMed ID: 9399390
    [Abstract] [Full Text] [Related]

  • 18. How do we offer clinical relief to patients with gastro-oesophageal reflux disease?
    Galmiche JP.
    Eur J Gastroenterol Hepatol; 2000 Jun 24; 12 Suppl 1():S3-6. PubMed ID: 10929891
    [Abstract] [Full Text] [Related]

  • 19. Medical treatment of gastro-oesophageal reflux disease.
    De Giorgi F, Savarese MF, Atteo E, Leone CA, Cuomo R.
    Acta Otorhinolaryngol Ital; 2006 Oct 24; 26(5):276-80. PubMed ID: 17345932
    [Abstract] [Full Text] [Related]

  • 20. Review article: current practice and future perspectives in the management of gastro-oesophageal reflux disease.
    Lambert R.
    Aliment Pharmacol Ther; 1997 Aug 24; 11(4):651-62. PubMed ID: 9305472
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.